Oxana Polyakova

1.2k total citations
15 papers, 377 citations indexed

About

Oxana Polyakova is a scholar working on Molecular Biology, Genetics and Geriatrics and Gerontology. According to data from OpenAlex, Oxana Polyakova has authored 15 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Geriatrics and Gerontology. Recurrent topics in Oxana Polyakova's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Skin and Cellular Biology Research (3 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Oxana Polyakova is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Skin and Cellular Biology Research (3 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Oxana Polyakova collaborates with scholars based in United Kingdom, France and United States. Oxana Polyakova's co-authors include Robin Dart, Susan John, Natalie Roberts, Salah Mansour, Iva Zlatareva, Peter M. Irving, Dieter Kabelitz, Oliver Nussbaumer, Daniela Wesch and Paul A. Bates and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Nature Immunology.

In The Last Decade

Oxana Polyakova

13 papers receiving 370 citations

Peers

Oxana Polyakova

IMMUN

ONCOL

Hye Song Lim South Korea

Tanjing Song China

Mei-Shiue Kuo France

Chareeporn Akekawatchai Thailand

Garrison Komaniecki United States

J. Peter McPherson Canada

Mariangela Storto Italy

M. Alkhalaf France

Vincenzo Gagliostro Italy

Jung‐Min Shin South Korea

Hye Song Lim South Korea

Oxana Polyakova

75 ×0.4

IMMUN

233 ×1.5

50 ×0.7

ONCOL

36 ×1.0

23 ×0.6

Citations per year, relative to Oxana Polyakova Oxana Polyakova (= 1×) peers Hye Song Lim

Countries citing papers authored by Oxana Polyakova

Since Specialization

Citations

This map shows the geographic impact of Oxana Polyakova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oxana Polyakova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oxana Polyakova more than expected).

Fields of papers citing papers by Oxana Polyakova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oxana Polyakova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oxana Polyakova. The network helps show where Oxana Polyakova may publish in the future.

Co-authorship network of co-authors of Oxana Polyakova

This figure shows the co-authorship network connecting the top 25 collaborators of Oxana Polyakova. A scholar is included among the top collaborators of Oxana Polyakova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oxana Polyakova. Oxana Polyakova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

McGinley, Aoife, et al.. (2024). Immunomodulatory alpha neutrophils: The first-in-class neutrophil progenitor-based allogeneic immuno-cell therapy with cytotoxic and immunomodulatory functionality for the treatment of solid tumours.. Journal of Clinical Oncology. 42(16_suppl). e14523–e14523. 1 indexed citations

Walker, Ann L., Ryan P. Bingham, Duncan S. Holmes, et al.. (2019). Structure guided drug design to develop kallikrein 5 inhibitors to treat Netherton syndrome. Bioorganic & Medicinal Chemistry Letters. 29(12). 1454–1458. 6 indexed citations

Thorpe, James H., Kathrine J. Smith, Xiao Qing Lewell, et al.. (2019). Evaluation of a crystallographic surrogate for kallikrein 5 in the discovery of novel inhibitors for Netherton syndrome. Acta Crystallographica Section F Structural Biology Communications. 75(5). 385–391. 2 indexed citations

Walker, Ann L., Alexis Denis, Ryan P. Bingham, et al.. (2019). Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(20). 126675–126675. 6 indexed citations

White, Gemma V., Duncan S. Holmes, Xiao Qing Lewell, et al.. (2019). Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome. Bioorganic & Medicinal Chemistry Letters. 29(6). 821–825. 8 indexed citations

Melandri, Daisy, Iva Zlatareva, Raphaël A. G. Chaleil, et al.. (2018). The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness. Nature Immunology. 19(12). 1352–1365. 167 indexed citations

Harling, John D., Angela M. Deakin, Sébastien Campos, et al.. (2013). Discovery of Novel Irreversible Inhibitors of Interleukin (IL)-2-inducible Tyrosine Kinase (Itk) by Targeting Cysteine 442 in the ATP Pocket. Journal of Biological Chemistry. 288(39). 28195–28206. 23 indexed citations

Grimley, Rachel L., Oxana Polyakova, Jessica Vamathevan, et al.. (2012). Over Expression of Wild Type or a Catalytically Dead Mutant of SIRTUIN 6 Does Not Influence NFκB Responses. PLoS ONE. 7(7). e39847–e39847. 26 indexed citations

Polyakova, Oxana, et al.. (2012). Identification of Novel Interacting Partners of Sirtuin6. PLoS ONE. 7(12). e51555–e51555. 21 indexed citations

10.

Grimley, Rachel L., Oxana Polyakova, Jessica Vamathevan, et al.. (2012). Correction: Over Expression of Wild Type or a Catalytically Dead Mutant of SIRTUIN 6 Does Not Influence NFκB Responses. PLoS ONE. 7(9). 1 indexed citations

11.

Moroz, Olga V., Helmut Wittkowski, Wei He, et al.. (2009). Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function. BMC Biochemistry. 10(1). 11–11. 97 indexed citations

12.

Polyakova, Oxana, Denise V. Dear, Stephen R. Martin, et al.. (2008). Proteolysis of prion protein by cathepsin S generates a soluble β-structured intermediate oligomeric form, with potential implications for neurotoxic mechanisms. European Biophysics Journal. 38(2). 209–218. 16 indexed citations

13.

Polyakova, Oxana. (1964). The biochemical mechanism of action of iodine solutions and ditrazine on enzymes of Dictyocaulus filaria.. 11. 127–132. 1 indexed citations

14.

Polyakova, Oxana, et al.. (1964). Effect of anthelmintics on the phosphorylase and aldolase activity of Ascaris muscle.. 11. 133–138. 1 indexed citations

15.

Polyakova, Oxana. (1959). The preparation and chemistry of some helminth antigens.. 6. 87–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact